PIPAC Pharmacologic and Clinical Data

Delia Cortés-Guiral; Onno Kranenburg; Olivia Sgarbura; Kurt Van Der Speeten; Albdelkader Taibi; Martin Hübner; Almog Ben Yacoov

doi:10.1002/jso.27900

PIPAC Pharmacologic and Clinical Data

Delia Cortés-Guiral^*, Onno Kranenburg, Olivia Sgarbura, Kurt Van Der Speeten, Albdelkader Taibi, Martin Hübner, Almog Ben Yacoov

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Abstract

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.

Original language	English
Pages (from-to)	1337-1348
Number of pages	12
Journal	Journal of Surgical Oncology
Volume	130
Issue number	6
Early online date	24 Sept 2024
DOIs	https://doi.org/10.1002/jso.27900
Publication status	Published - Nov 2024

Keywords

clinical results
peritoneal metastasis
pharmacology
PIPAC

Access to Document

10.1002/jso.27900

Cite this

@article{8a464e6857dc40ad998c6d509eec7ca5,

title = "PIPAC Pharmacologic and Clinical Data",

abstract = "Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.",

keywords = "clinical results, peritoneal metastasis, pharmacology, PIPAC",

author = "Delia Cort{\'e}s-Guiral and Onno Kranenburg and Olivia Sgarbura and {Van Der Speeten}, Kurt and Albdelkader Taibi and Martin H{\"u}bner and Yacoov, {Almog Ben}",

note = "Publisher Copyright: {\textcopyright} 2024 Wiley Periodicals LLC.",

year = "2024",

month = nov,

doi = "10.1002/jso.27900",

language = "English",

volume = "130",

pages = "1337--1348",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - PIPAC Pharmacologic and Clinical Data

AU - Cortés-Guiral, Delia

AU - Kranenburg, Onno

AU - Sgarbura, Olivia

AU - Van Der Speeten, Kurt

AU - Taibi, Albdelkader

AU - Hübner, Martin

AU - Yacoov, Almog Ben

PY - 2024/11

Y1 - 2024/11

N2 - Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.

AB - Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.

KW - clinical results

KW - peritoneal metastasis

KW - pharmacology

KW - PIPAC

UR - http://www.scopus.com/inward/record.url?scp=85204684265&partnerID=8YFLogxK

U2 - 10.1002/jso.27900

DO - 10.1002/jso.27900

M3 - Review article

AN - SCOPUS:85204684265

SN - 0022-4790

VL - 130

SP - 1337

EP - 1348

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

IS - 6

ER -

PIPAC Pharmacologic and Clinical Data

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this